Federal Government’s TGA reforms to make regulation “more effective and transparent”
After seven reviews of Australia’s Therapeutic Goods Administration (TGA) in less than 18 months, the Federal Government today announced “comprehensive reforms” for Australia’s Therapeutic Goods Administration (TGA), the Federal agency for the therapeutic products industry.
Releasing ‘TGA reforms: A blueprint for TGA’s future’ today, The Parliamentary Secretary for Health and Ageing, Catherine King, admitted the TGA regulatory system had given rise to concerns from consumers, health professionals and industry.
Ms King said the concerns related to the effectiveness of complementary medicines, their promotion and adequate evaluation of some high risk medical devices.
She said that over the past 18 months the government has received more than170 public submissions across the seven separate reviews into the operations of the TGA.
She admitted the TGA has not tested the so-called “low risk products” for their efficacy.
“These reforms are well overdue,” she said. “The reforms will be designed to strengthen the response to unsubstantiated claims on labels or in advertising.”
Ms King said the reforms would be implemented in stages.